Approval of Rytelo could provide patients with lower-risk myelodysplastic syndromes with extended periods without the need ...

Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur, in an ...

Deerfield Agency announced that it has agreed to acquire healthcare marketing and advertising firm Embedded. 1 After the ...

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, ...

Blue Cross Blue Shield of Massachusetts announced that it is expanding support for LGBTQIA+ members. 1 This includes greater ...

EVERSANA INTOUCH Media’s EVP discusses how the ban may impact the industry and how companies can prepare for it.

Eli Lilly and Company announced that Anat Ashkenazi has decided to step down as chief financial officer. 1 She will continue ...

A similar application was also submitted to the EMA for the expanded use of Prezcobix to treat children aged 6 years and ...

In a majority vote, the Psychopharmacologic Drugs Advisory Committee cited concerns regarding the data presented for MDMA as ...

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, ...

According to the manufacturer, the LFR-260 features advanced technology that allows patients to compare multiple prescriptions simultaneously, eliminating the need for traditional refraction methods.

Data published in the New England Journal of Medicine from Gilead’s Phase IIb MYR204 found the bulevirtide/ pegylated ...